Recent Advances in the Synthesis of Oxazole-Based Molecules via van Leusen Oxazole Synthesis.
TosMICs
oxazole
synthesis
van Leusen
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
31 Mar 2020
31 Mar 2020
Historique:
received:
02
03
2020
revised:
19
03
2020
accepted:
23
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
29
12
2020
Statut:
epublish
Résumé
Oxazole compounds, including one nitrogen atom and one oxygen atom in a five-membered heterocyclic ring, are present in various biological activities. Due to binding with a widespread spectrum of receptors and enzymes easily in biological systems through various non-covalent interactions, oxazole-based molecules are becoming a kind of significant heterocyclic nucleus, which have received attention from researchers globally, leading them to synthesize diverse oxazole derivatives. The van Leusen reaction, based on tosylmethylisocyanides (TosMICs), is one of the most appropriate strategies to prepare oxazole-based medicinal compounds. In this review, we summarize the recent advances of the synthesis of oxazole-containing molecules utilizing the van Leusen oxazole synthesis from 1972, aiming to look for potential oxazole-based medicinal compounds, which are valuable information for drug discovery and synthesis.
Identifiants
pubmed: 32244317
pii: molecules25071594
doi: 10.3390/molecules25071594
pmc: PMC7180750
pii:
doi:
Substances chimiques
Oxazoles
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
ACS Omega. 2017 Oct 02;2(10):6291-6297
pubmed: 31457237
Bioorg Med Chem Lett. 2015 Nov 15;25(22):5178-81
pubmed: 26459210
Bioorg Med Chem. 2014 Jul 1;22(13):3478-87
pubmed: 24837158
J Org Chem. 2000 Mar 10;65(5):1516-24
pubmed: 10814116
Front Chem. 2019 Jun 14;7:433
pubmed: 31259168
Eur J Med Chem. 2017 Jan 27;126:1021-1033
pubmed: 28012342
Molecules. 2017 Dec 06;22(12):
pubmed: 29210998
Eur J Med Chem. 2018 Jan 20;144:444-492
pubmed: 29288945
Eur J Med Chem. 2017 Jan 27;126:669-674
pubmed: 27936445
Eur J Med Chem. 2013 Nov;69:32-43
pubmed: 23999140
Molecules. 2018 Oct 17;23(10):
pubmed: 30336556
Eur J Med Chem. 2017 Mar 10;128:25-35
pubmed: 28152426
Bioorg Med Chem. 2013 Aug 1;21(15):4541-9
pubmed: 23773956
Beilstein J Org Chem. 2014 Sep 18;10:2222-9
pubmed: 25246981
Eur J Med Chem. 2012 Jul;53:283-91
pubmed: 22560632
Eur J Med Chem. 2017 May 26;132:333-340
pubmed: 28411559
Beilstein J Org Chem. 2019 Mar 13;15:655-678
pubmed: 30931007
Bioorg Med Chem Lett. 2014 Nov 1;24(21):5045-9
pubmed: 25266782
Bioorg Med Chem Lett. 2015 Jan 15;25(2):313-6
pubmed: 25488842
Org Biomol Chem. 2019 Jul 17;17(28):6735-6747
pubmed: 31250862
J Am Chem Soc. 2015 Sep 9;137(35):11206-9
pubmed: 26301427
Expert Opin Ther Pat. 2018 Nov;28(11):783-812
pubmed: 30239247
Eur J Med Chem. 2015 Apr 13;94:252-64
pubmed: 25768707
Curr Opin Chem Biol. 2008 Jun;12(3):324-31
pubmed: 18312861
Bioorg Med Chem Lett. 2014 Jan 1;24(1):386-9
pubmed: 24269122
Pharmaceuticals (Basel). 2020 Mar 03;13(3):
pubmed: 32138202
J Org Chem. 2011 Apr 15;76(8):2904-8
pubmed: 21388233
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3105-11
pubmed: 26096679
Bioorg Med Chem. 2020 Jan 1;28(1):115210
pubmed: 31753802
Bioorg Med Chem. 2016 Nov 1;24(21):5410-5417
pubmed: 27647373
J Med Chem. 2014 Feb 13;57(3):1079-89
pubmed: 24456116
European J Org Chem. 2015 Mar;2015(7):1602-1605
pubmed: 26236153
Eur J Med Chem. 2013 Sep;67:208-20
pubmed: 23867605
BMC Chem. 2019 Feb 4;13(1):16
pubmed: 31384765
Bioorg Med Chem Lett. 2014 Nov 1;24(21):4984-8
pubmed: 25288185
Molecules. 2019 Apr 04;24(7):
pubmed: 30987302
Bioorg Med Chem. 2013 Nov 1;21(21):6385-97
pubmed: 24075144
ACS Chem Biol. 2016 Apr 15;11(4):1128-36
pubmed: 26828310
Bioorg Med Chem Lett. 2013 May 15;23(10):2888-92
pubmed: 23566519
Curr Med Chem. 2019;26(41):7337-7371
pubmed: 30501590
Fitoterapia. 2013 Jan;84:318-20
pubmed: 23266734
Angew Chem Int Ed Engl. 2011 Sep 5;50(37):8745-9
pubmed: 21812083